{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-24-000045","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2024-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.243595+00:00","generated_at":"2026-05-31T06:32:07.496686+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Myriad Genetics discontinues part two of GeneSight study; control group deemed unreliable","bullets":["Part one (April 2024) showed 29% drop in all-cause hospitalizations and 39% drop in psychiatric-related hospitalizations 180 days post-GeneSight.","Part two aimed to compare GeneSight patients vs. matched non-GeneSight control; significant baseline disparities made control group non-viable.","Company concluded data comparing the two groups were not reliable and halted the analysis.","GeneSight's causal role in hospitalization reduction remains unconfirmed without a valid control group.","Company plans to publish full part one results in the near future."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-24-000045","json":"https://secwatch.observer/filing/0000899923-24-000045.json","markdown":"https://secwatch.observer/filing/0000899923-24-000045.md","text":"https://secwatch.observer/filing/0000899923-24-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992324000045/0000899923-24-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992324000045/mygn-20240904.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:32:07.496686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}